Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06251011Not ApplicableCompleted

Effects of Physiotherapy Via Telerehabilitation in Patients With COVID-19

Role: lead

NCT03359187Not ApplicableCompleted

Prevention of Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy

Role: lead

NCT03003091Not ApplicableCompleted

Needs-Based Patient Education Versus Traditional Patient Education in Reducing Pre-operative Anxiety in Day Surgery

Role: lead

NCT02768428Not ApplicableUnknown

Effectiveness of Knowledge by Video and Handbook of Liver Cancer Patients With First Trans-arterial Chemoembolization

Role: lead

All 4 trials loaded